Estrella Immunopharma, Inc. Common Stock

ESLA XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

46M

Short interest (May 15)

0.2%

Net Short (Jun 03 ): 0.0%

Borrow Fee

15.60%

↑ 1.5%

Available Shares

↓ 0.0%

Price Chart

Company Overview

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001844417

Asset Type: CS

Market Data

Market Cap: $46,476,966

Status: Active

Short Interest

Current Borrow Fee 15.60%

Range: 15.56% - 15.67%

Available Shares 4M

Range: 4.1M - 4.2M

Recent Changes

Fee Change: ↓ 2.7%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime